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WS23.1 Progression of lung disease within speciﬁc genotypes of
patients with cystic ﬁbrosis (CF) − Which lung function
parameter differentiates best?
S. Gallati1, M.H. Schoeni2, R. Kraemer3. 1University of Berne, Division of Human
Genetics, Berne, Switzerland; 2University of Berne, Department of Paediatrics,
Berne, Switzerland; 3University of Berne, Division of Paediatrics Respiratory
Medicine, Berne, Switzerland
Objectives: The relationship between CFTR genotypes and functional severity of
pulmonary disease in CF has been proven to be difﬁcult to establish. In contrast
to previous modelling concepts we stratiﬁed genotypes according to the nature of
mutations in combination with and without F508del and searched for associations
with different lung function parameters (FRCpleth, LCI, VTG, sReff , FEV1, FEF50)
Methods: Longitudinal data included repeated measurements of 246 CF patients
(124 males; 122 females) aged between 5 and 18 years annually seen between
1987 and 2010. Linear mixed model (LMM) analyses were used to analyse the
relationship between each lung function parameter regarding progression with age
(slope) and speciﬁc genotypes:
A. F508del(2); n = 144 vs. F508del_frameshift; n = 27 vs. nonF508del_frameshift;
n = 10
B. F508del(2); n = 144 vs. F508del_nonsense; n = 27 vs. nonF508del_nonsense;
n = 11
C. F508del(2); n = 144 vs. F508del_missense; n = 10 vs. nonF508del_missense;
n = 9
Results: The degree of bronchial obstruction (sReff ) signiﬁcantly (p< 0.01) de-
creased with age in nonF508del_frameshift genotypes, ventilation inhomogeneities
(LCI) and bronchial obstruction were less pronounced in nonF508del_nonsense
groupe, and increase of bronchial obstruction as well as decline in ﬂow limitation
(FEV1, MEF50) were signiﬁcantly lower in nonF508del_missense patients.
Conclusions: Nature and combination with or without F508del are important
stratifying criteria for genotype–phenotype modelling in CF. Extended lung function
evaluation is crucial to provide reliable estimate of disease progression and to allow
prognostic conclusions.
WS23.2 Chest X-ray scores and chest CT scores up to 5 years apart
are highly correlated
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Background: We recently demonstrated that: (1) the Wisconsin x-ray scoring
system (WCXR) is highly sensitive to chest CT abnormalities for chest x-rays
obtained within one year of the CT; (2) WCXR scores are strongly predictive of
WCXR and FEV1 severity 5−7 years later. In this study, we hypothesize that WCXR
scores obtained up to 5 years before and after a chest CT would be correlated with
the Brody CT score.
Methods: In 2000, 81 subjects in the Wisconsin Randomized Control Trial of CF
Newborn Screening obtained a high-resolution chest CT at their clinical baseline.
Chest x-rays and spirometry were performed annually. The sensitivity, ROC, and
correlation between the 2000 Brody CT score and annual WCXR and FEV1
% predicted obtained between 5 years before and 5 years after the chest CT were
calculated.
Results: In 2000, the mean (range) age was 11.6 (6.6–17.6) years. During the 10-
year study period, the mean (SD) WCXR worsened from 10.2 (9.6) to 23.4 (14.5);
the mean (SD) FEV1 % predicted remained stable: 91.8 (23.4) in the ﬁrst year and
92.3 (18.3) in the last year. The correlation between WCXR scores and the CT score
ranged from 0.72 to 0.84. In contrast, the correlation between FEV1 and CT scores
ranged from −0.49 to −0.76. The WCXR correlation was statistically signiﬁcantly
better than the FEV1 correlation in the 4 years before the CT and years 2−4 after.
Conclusion: There is a strong correlation between annual WCXR scores and
chest CT score for a period up to 5 years before and 5 years after the CT. Over a
10-year period, longitudinal WCXR scores compare favorably with chest CT and
provide more prognostic information on lung disease progression than does FEV1.
WS23.3 Sputum Candida albicans is associated with radiological
abnormalities in a cystic ﬁbrosis cohort
T. McEnery1, S.H. Chotirmall1, T. Hassan1, B. McCullagh1, Z. Abidin1,
S.J. O’Neill1, C. Gunaratnam1, M.P. Logan2, N.G. McElvaney1. 1Beaumont
Hospital, Department of Respiratory Medicine, Dublin, Ireland; 2Beaumont
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Introduction: C. albicans is commonly isolated from CF sputum and is associated
with impaired salivation, diabetes, steroid and antibiotic use. Recent data suggest
that the organism presages hospitalized exacerbations and FEV1 declines [1].
Aim: To determine effect of C. albicans colonization on high resolution computed
tomography (HRCT) chest imaging in a CF cohort (n = 48).
Methods: All patients were evaluated by HRCT and classiﬁed according to
C. albicans colonization status over the preceding 2-year period. Modiﬁed bhalla
scoring criteria was applied to each scan by a radiologist blinded to colonization
status and statistical analysis performed using SPSSv17 software.
Results: Patients colonized with C. albicans (n = 23) show more severe bronchiec-
tasis (p< 0.03) and peribronchial thickening (p< 0.05) as compared to those non-
colonized (n = 25). Signiﬁcant differences were also detected in the C. albicans
colonized for the extent of bronchiectasis (p = 0.025), mucus plugging (p = 0.032),
lymphadenopathy (p = 0.022) and mosaic pattern (p = 0.022). No differences were
detected in the presence of sacculations, abscesses, bullae, emphysema, collapse,
consolidation or broncholiths.
Conclusion: CF patients colonized by C. albicans show more severe radiological
abnormalities as compared to those non-colonized. In combination with prior
data [1], identiﬁcation of C. albicans should prompt radiological evaluation. Studies
assessing the efﬁcacy of therapeutic eradication in CF are now warranted.
Reference(s)
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WS23.4 High Rhinovirus burden in lower airways of children with
cystic ﬁbrosis
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Background: Rhinovirus (RV)-induced pulmonary exacerbations are common in
cystic ﬁbrosis (CF) and have been associated with impaired virus clearance by the
CF airway epithelium in vitro.
Objective: To assess in vivo the association of RV prevalence and load with anti-
viral defence mechanisms, airway inﬂammation and lung function parameters in
children with CF as compared to children with other chronic respiratory diseases
and controls.
Methods: RV presence and load was measured by real-time RT-PCR in bron-
choalveolar lavage (BAL) samples and related to anti-viral and inﬂammatory
mediators measured in BAL and to clinical parameters.
Results: BAL samples were obtained from children with CF (n = 195), non-CF
bronchiectasis (n = 40), asthma (n = 29) and controls (n = 35) at a median (IQR) age
of 8.2 (4.0–11.7) years. RV was detected in 73 samples (24.4%). RV prevalence
was similar between groups. RV load (median [IQR] ×103 copies/mL) was higher
in CF (143.0 [13.1–1530.0]), especially during pulmonary exacerbations, compared
to asthmatics (3.0 [1.3–25.8], p = 0.006) and controls (0.5 [0.3−0.5], p< 0.001),
but similar to non-CF bronchiectasis (122.1 [2.7–4423.5], p =NS). In children with
CF, RV load was negatively associated with IFN-b/-l, IL-r1a levels and FEV1, and
positively with IL-8 and IP-10 levels.
Conclusion: RV load in CF BAL is high, especially during exacerbated lung
disease. Impaired production of anti-viral mediators, possibly as a consequence
of inﬂammation, may lead to the high RV burden in the lower airways of children
with CF.
